Case study

Andwise: executive build-out of fiduciary-safe decision infrastructure

As Co-founder & CEO, built company-wide governance, clinical advisory operations, and risk architecture for high-stakes financial guidance.

Organization

Andwise

Timeframe

2022–2024

Focus

Redacted, de-identified outcomes

Overview

Case study overview

A redacted summary of the system, constraints, and outcomes.

Summary

As Co-founder & CEO, built company-wide governance, clinical advisory operations, and risk architecture for high-stakes financial guidance.

Clinicians wanted actionable guidance without opaque sales pressure or compliance risk.

Problem

As Co-founder & CEO, built company-wide governance, clinical advisory operations, and risk architecture for high-stakes financial guidance.

Intervention

Built and governed a 60-member medical advisory board as core operating infrastructure.

Impact

High-risk recommendations moved faster because review ownership and escalation pathways were explicit.

Andwise

2022–2024

Case study detail

Constraints

  • Fiduciary duty, legal review, and audit-trace requirements.
  • High-stakes decision anxiety for clinicians and advisors.
  • Need for transparent executive-to-operator ownership in overrides.

Interventions

  • Built and governed a 60-member medical advisory board as core operating infrastructure.
  • Designed risk architecture for high-risk routing, review SLAs, and escalation clocks.
  • Implemented plain-language summaries with accountable sign-off and override custody.

Outcomes

  • High-risk recommendations moved faster because review ownership and escalation pathways were explicit.
  • Overrides became easy to inspect with executive-to-operator decision context attached.
  • Clinicians reported higher trust in the advisory process and resulting guidance.

Artifacts

  • Medical advisory board governance charter (redacted).
  • Risk routing matrix with escalation timers and owner SLAs.
  • Executive review + override custody checklist.